PTIX
Protagenic Therapeutics, Inc.newCompany with tickers: PTIX, PTIXW
CIK
1022899
CUSIP
74365N301
Shares Outstanding
1,810,208
Website
https://protagenic.com
Investor Relations
https://protagenic.com/investor-relations
13F Activity (30d)
2 filings
1 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Recent quarters
| Quarter Ended | Cash Spent | Source |
|---|---|---|
| 2010-09-30 | $0 Δ | 10-Q, filed 2011-11-14 |